Navigation Links
Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer
Date:8/4/2010

CAMBRIDGE, Mass., Aug. 4 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the appointment of Antonin (Tony) de Fougerolles, Ph.D., as Chief Scientific Officer. Dr. de Fougerolles’ appointment as Tolerx’s CSO will provide leadership for the company’s research and early-stage product development programs involving novel therapies based on T cell modulation.  Dr. de Fougerolles brings to Tolerx more than 15 years of biotech R&D experience and expertise in immunology. He will direct the company’s R&D activities and strengthen Tolerx’s leadership in T cell immunology.

(Photo: http://photos.prnewswire.com/prnh/20100804/NE45601 )

(Photo: http://www.newscom.com/cgi-bin/prnh/20100804/NE45601 )

"We are delighted and enthusiastic about Tony joining us as CSO at this pivotal time, when Tolerx is poised to make substantial progress in expanding our pipeline of drug candidates based on T cell modulation,"
'/>"/>

SOURCE Tolerx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tolerx Initiates Confirmatory Phase 3 Clinical Trial, DEFEND-2, with Otelixizumab for Type 1 Diabetes
2. Tolerx Presents Baseline Data from DEFEND-1 Study Validating C-Peptide as Critical Clinical Measure for New-Onset Type 1 Diabetes
3. Tolerx Presents Preclinical Data on Novel T-cell Modulator, TRX518, for Antitumor Immune Response at Federation of Clinical Immunology Societies Scientific Meeting
4. Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association
5. Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial
6. Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
7. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
8. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
9. InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing
10. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
11. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 Passport Health, one ... , has launched FluFree.com, a website designed to ... For 20 years, Passport Health has provided ... flu. The launch of FluFree.com is designed to address ... the number of people who actually chose to get ...
(Date:9/30/2014)... September 2014 ... Acutus Medical, Inc. ... 3D-Herzkammer-Bildgebungs- und Dipoldichte-Mappingsystem in Echtzeit zur ... komplexen Herzrhythmusstörungen einschließlich Vorhofflimmern führen bzw. ... zusätzlichen Finanzierung über 26,2 Mio. USD ...
(Date:9/30/2014)... , Sept. 30, 2014  Arena Solutions, the ... today announced its Fall 2014 release, which includes ... and Arena DataExtract – and significant ... available products are focused specifically on speeding time ... aggregation of a complete history of tribal knowledge ...
Breaking Medicine Technology:Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 2Passport Health Launches FluFree.com - Aims To Improve Flu Vaccination Rates and Fulfill Growing Public Health Priority 3Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 2Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 3Arena Unveils Unique PLM Collaboration Platform And New Data Extraction Tool 2Arena Unveils Unique PLM Collaboration Platform And New Data Extraction Tool 3Arena Unveils Unique PLM Collaboration Platform And New Data Extraction Tool 4
(Date:9/30/2014)... Legislation passed in 2003 to slow the spiraling ... to treat Medicare patients has had no meaningful impact ... researchers in the Journal of Clinical Oncology ... outpatient chemotherapy to treat colorectal and lung cancers, and ... prescribe those drugs following the implementation of the recent ...
(Date:9/30/2014)... September 30, 2014 Integrated Medicine ... is opening another new medical specialty practice through a ... Cardiology will be located within the company’s Shrewsbury ... and Dr. Isaac Tawfik of American Heart Center, P.C., ... new practice will offer Integrated Medicine Alliance patients top ...
(Date:9/30/2014)... of allergy-related sudden deaths in the U.S., according to ... conducted by researchers at Montefiore Medical Center ... Yeshiva University . The study, published online today in ... also found that the risk of fatal drug-induced allergic ... and that such deaths increased significantly in the U.S. ...
(Date:9/30/2014)... EverStryke , the permanent match currently ... along with a free book and class all about survival ... prompting an investigative review. , “Joe Marshall of SurvivalLife.com ... and preparation niche, and this product is an excellent way ... survival products that Joe offers on his website to help ...
(Date:9/30/2014)... The American Diabetes Association ... curb their sweet tooth, but the most recent research, ... suggests that zero-calorie sweeteners may actually be linked to ... The Weizmann Institute of Science in Israel recently ... mice, the mice developed glucose intolerance. They then analyzed ...
Breaking Medicine News(10 mins):Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:Comprehensive Study of allergic deaths in US finds medications are main culprit 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2
... Medical Data ... the healthcare industry has announced the expansion in to Primary Collections Operations, and the opening ... ... industry leader, Medical Data Systems, Inc. (MDS), has announced the opening of its ...
... Reportlinker.com just added a new market research ... World Multiple Myeloma Therapeutics Market ... , , This ... Therapeutics in Millions of US$. The market for ...
... SCAN Health Plan announced today that it has hired ... services, effective immediately. Taylor-Laws brings more than 25 years ... vice president Taylor-Laws will be responsible for the development ... on behalf of SCAN,s members throughout Maricopa County. "Access ...
... 7 Twenty-one regional hospitals that utilize ... (INHS) earned the distinction of being among the most ... the 2009 Most Wired Survey and Benchmarking Study released ... Networks magazine. Hospitals and Health Networks ...
... for American Medical Innovation headlined a forum on medical ... Health. Former Democratic Majority Leader Richard Gephardt, president ... in Indiana government, academia and business for a panel ... and what is needed to maintain a robust environment ...
... The Anthropedia Foundation, a non-profit organization based in ... Yourself , an innovative DVD series designed for people ... lives. The series is a step-by-step guide to improving ... on straightforward concepts and simple exercises that foster calmness, ...
Cached Medicine News:Health News:Medical Data Systems, Inc. (MDS) Announces Operations Expansion and Opening of its Primary Collections Operations Office 2Health News:Medical Data Systems, Inc. (MDS) Announces Operations Expansion and Opening of its Primary Collections Operations Office 3Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 2Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 3Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 4Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 5Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 6Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 7Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 8Health News:New Report Just Published: World Multiple Myeloma Therapeutics Market Report 9Health News:SCAN Health Plan Selects Kathy Taylor-Laws as Vice President of Network Management Services 2Health News:21 Regional Hospitals Recognized as Nation's Most Wired 2Health News:21 Regional Hospitals Recognized as Nation's Most Wired 3Health News:Council for American Medical Innovation and Hoosiers Work for Health Host Indiana Forum on Medical Innovation 2Health News:Knowing Yourself Can Improve Your Health and Happiness 2Health News:Knowing Yourself Can Improve Your Health and Happiness 3
... oxygen flowmeters., ,Options: , ... S to model number. Example: ... add suffix C to model ... Double Flowmeters with Power Take-Off, ...
... flowmeters., ,Options: , For ... to model number. Example: FMC107S. ... suffix C to model number. ... Flowmeters with Power Take-Off, add ...
... Slim Line Flowmeters with brass and ... security chain, add suffix S to ... Canadian Color-Code, add suffix C to ... Double Flowmeters with Power Take-Off, add ...
... Flowmeters with brass and aluminum body., ... add suffix S to model number. ... add suffix C to model number. ... with Power Take-Off, add PT to ...
Medicine Products: